High Hopes For Stent Antiplatelet Therapy Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Planned $100 million, 30-month study aims to allay stent safety concerns, guide anti-platelet good practice .
You may also be interested in...
Major Trials On Dual-Antiplatelet Therapy For DES In The Works
The four major drug-eluting stent manufacturers are negotiating the design of a clinical trial that will help determine the optimal duration of concomitant dual-antiplatelet therapy for patients with a drug-eluting stent, according to Boston Scientific
Confusion Over Anti-Clotting Therapy Hinders Drug-Eluting Stent Rebound
Blanket recommendations for one year of dual antiplatelet therapy for patients who receive drug-eluting stents may be the biggest cloud over the market for the devices, cardiologists suggest
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.